Gary Owens, MD, president of Gary Owens Associates, outlines the current epidemiological knowledge of pulmonary arterial hypertension (PAH).
Pulmonary arterial hypertension (PAH) tends to affect younger people as opposed to those in older age groups and females more than males, said Gary Owens, MD, president of Gary Owens Associates.
Transcript
What opportunities exist to improve the time from symptom onset to diagnosis of PAH?
We do know a little bit about the epidemiology of this disease. It tends to affect people in younger, rather than older, age groups. Again, we're talking about pulmonary arterial hypertension. It does tend to affect females more often than males and has a bit of a predilection for Caucasian females in particular.
So, [the] number one way to improve it is an index of suspicion for this disease. And so with presentation of first symptoms, a lot of the initial diagnostic tests should be done fairly quickly. Things like cardiac workups, pulmonary function testing, those sorts of things, and then rapidly, if that doesn't find a cause, move into things ruling out sleep apnea is another thing you need to do. Then getting into more advanced imaging.
But ultimately, one probably needs to make early referrals if you suspect this diagnosis, because really the diagnosis of pulmonary arterial hypertension rests on demonstrating an elevated mean pulmonary arterial pressure, which has to be done, in essence, by a right heart [catheterization], as well as an increase in pulmonary vascular resistance.
I guess what I'm saying it takes a high index of suspicion and awareness and a willingness to go through the initial diagnostic activities quickly and make referrals when appropriate. And that can probably be the best thing to improve outcomes.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More